Skip to Main Content
Legislation Search

S. 2531: Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the early detection and treatment of uterine fibroids, a common health issue among women. Here are the key points of the bill:

Purpose of the Act

The Act authorizes the Secretary of Health and Human Services (HHS) to:

  • Conduct or support research focused on enhancing the early detection and intervention of uterine fibroids.
  • Develop evidence-based or evidence-informed strategies based on research findings to improve detection in healthcare settings.

Grant Programs

The bill allows the Secretary to award grants to states for several purposes related to uterine fibroids:

  • Increase early detection and intervention programs.
  • Develop and implement public awareness and educational campaigns regarding uterine fibroids.

Use of Grant Funds

States receiving grants can utilize the funds for various activities aimed at enhancing the early detection and intervention of uterine fibroids, including:

  • Screening procedures, which may cover advanced gynecological imaging costs.
  • Patient navigation services to assist individuals in accessing healthcare.
  • Implementation of the evidence-based strategies developed by HHS.
  • Improving access to healthcare settings for screenings and treatments.

Research Focus

The Secretary may also award grants specifically designated for research that includes clinical trials. Areas of research could involve:

  • Disparities in pain control and management for those undergoing surgical treatment for uterine fibroids.
  • Conditions such as Asherman's Syndrome and other intrauterine adhesions.

Reporting Requirements

The Secretary of HHS must report to Congress on the activities resulting from grants awarded under this Act:

  • A summary report of findings and results from funded programs will be submitted within two years of the initial grant awards, and every two years thereafter.
  • Include updates on research findings concerning pain management in surgical treatments for uterine fibroids and information regarding related uterine conditions.

Overall Aim

The overall objective of the bill is to enhance the understanding, management, and treatment of uterine fibroids, ultimately aiming to improve women's health outcomes related to this condition.

Relevant Companies

None found

This is an AI-generated summary of the bill text. There may be mistakes.

Show More

Sponsors

2 bill sponsors

Actions

2 actions

Date Action
Jul. 30, 2025 Introduced in Senate
Jul. 30, 2025 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Corporate Lobbying

0 companies lobbying

None found.

* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.

Potentially Relevant Congressional Stock Trades

No relevant congressional stock trades found.